TCRCure Biopharma
Latest round
- Series B
Last raised
- Feb 2022
Total raised
- $47M
Investors
- 9
About TCRCure Biopharma
Established in 2016 and based in Chongqing, China, TCRCure Biopharma Ltd. operates as a tumor immune cell therapy technology developer that focuses on provides immunodiagnosis and precision medicine solution. The company has more than 150 employees and more than 40% members of its total employees have master's degree. The company cooperates with many hospitals such as Sun Yat-sen Medical University Cancer Hospital, Xinqiao Hospital, West China Hospital. The company developed TCR screening platform (TRUST) in May 2017. The company passed the GMP audit in November 2020. The company initated TC-E202 registration phase I study in December 2021. The company provides immunodiagnosis and precision medicine solution for many patients with lung cancer, liver cancer and cervical cancer. The company's products include CAR-T, TCR-T, CAR-NK and TIL immune cell therapy products. The company's technology platform includes TRUST platform, CHECK-T cell engineering platform and TURBO-T cell engineering platform. The company will invest in immune cell products R&D, expanding product line and constructing team.
Who invested in TCRCure Biopharma
9 investors across 3 rounds
See all investors in TCRCure Biopharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about TCRCure Biopharma
Who invested in TCRCure Biopharma?
TCRCure Biopharma has 9 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has TCRCure Biopharma raised?
TCRCure Biopharma has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did TCRCure Biopharma last raise money?
TCRCure Biopharma's most recent round on record is a Series B, in Feb 2022.
What does TCRCure Biopharma do?
Established in 2016 and based in Chongqing, China, TCRCure Biopharma Ltd.
Where is TCRCure Biopharma headquartered?
TCRCure Biopharma is headquartered in Chongqing, China.
Which VCs invest in companies like TCRCure Biopharma?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at TCRCure Biopharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like TCRCure Biopharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.